Castleview Partners, LLC Opko Health, Inc. Transaction History

Castleview Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$1.21 - $1.42 $24,140 - $28,330	-19,951 Reduced 86.93%	3,000 $3,000
Q4 2023 Feb 05, 2024	SELL	$1.23 - $1.63 $12,915 - $17,115	-10,500 Reduced 31.39%	22,951 $34,000
Q3 2022 Nov 10, 2022	BUY	$1.81 - $2.81 $59,666 - $92,631	32,965 Added 6782.92%	33,451 $63,000
Q2 2022 Aug 17, 2022	SELL	$2.33 - $3.61 $196,057 - $303,763	-84,145 Reduced 99.43%	486 $1,000
Q2 2022 Aug 16, 2022	BUY	$2.33 - $3.61 $119,249 - $184,759	51,180 Added 153.0%	84,631 $214,000
Q1 2022 May 16, 2022	BUY	$2.87 - $4.93 $47,687 - $81,916	16,616 Added 98.7%	33,451 $115,000
Q4 2021 Feb 17, 2022	SELL	$3.52 - $5.15 $58,488 - $85,572	-16,616 Reduced 49.67%	16,835 $80,000
Q2 2021 Aug 17, 2021	BUY	$3.33 - $4.55 $3,330 - $4,550	1,000 Added 3.08%	33,451 $135,000
Q1 2018 May 07, 2018	BUY	$3.11 - $5.12 $100,922 - $166,149	32,451 New	32,451 $103,000

255

187M

6.03M

10.1M

Ticker OPK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 771,960,000
Market Cap $1.19B
Description
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Castleview Partners, LLC with notifications on news.